Bionomics Limited (BNOX)
NASDAQ: BNOX · Real-Time Price · USD
0.197
-0.003 (-1.25%)
At close: Nov 1, 2024, 4:00 PM
0.190
-0.006 (-3.30%)
After-hours: Nov 1, 2024, 7:37 PM EDT

Bionomics Statistics

Total Valuation

Bionomics has a market cap or net worth of $3.41 million. The enterprise value is -$8.96 million.

Market Cap 3.41M
Enterprise Value -8.96M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

Bionomics has 17.32 million shares outstanding. The number of shares has increased by 22.39% in one year.

Shares Outstanding 17.32M
Shares Change (YoY) +22.39%
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) 8.87%
Float 15.00M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.15
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.45, with a Debt / Equity ratio of 0.01.

Current Ratio 3.45
Quick Ratio 3.33
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -78.44% and return on invested capital (ROIC) is -55.49%.

Return on Equity (ROE) -78.44%
Return on Assets (ROA) -39.58%
Return on Capital (ROIC) -55.49%
Revenue Per Employee n/a
Profits Per Employee -$645,507
Employee Count 24
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -87,320
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -92.00% in the last 52 weeks. The beta is -0.16, so Bionomics's price volatility has been lower than the market average.

Beta (5Y) -0.16
52-Week Price Change -92.00%
50-Day Moving Average 0.46
200-Day Moving Average 0.79
Relative Strength Index (RSI) 31.41
Average Volume (20 Days) 1,660,798

Short Selling Information

Short Interest 13,778
Short Previous Month 72,985
Short % of Shares Out 0.08%
Short % of Float 0.09%
Short Ratio (days to cover) 0.05

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -17.80M
Pretax Income -20.43M
Net Income -15.49M
EBITDA -17.35M
EBIT -17.80M
Earnings Per Share (EPS) -$1.55
Full Income Statement

Balance Sheet

The company has $12.61 million in cash and $239,618 in debt, giving a net cash position of $12.37 million or $0.71 per share.

Cash & Cash Equivalents 12.61M
Total Debt 239,618
Net Cash 12.37M
Net Cash Per Share $0.71
Equity (Book Value) 17.49M
Book Value Per Share 1.32
Working Capital 9.36M
Full Balance Sheet

Cash Flow

Operating Cash Flow -14.68M
Capital Expenditures n/a
Free Cash Flow -14.68M
FCF Per Share -$0.85
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -117,031.23%

Dividends & Yields

Bionomics does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -22.39%
Shareholder Yield -22.39%
Earnings Yield -454.27%
FCF Yield -430.47%

Analyst Forecast

The average price target for Bionomics is $8.00, which is 3,962.98% higher than the current price. The consensus rating is "Strong Buy".

Price Target $8.00
Price Target Difference 3,962.98%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1